Ocumetics Technology Corp. focuses on developing vision enhancement products, particularly expandable intraocular lenses. A significant concern is its negative return on assets (ROA) of -108.4%, indicating inefficiency in generating profits from its assets. Additionally, the current ratio of 0.09 raises liquidity concerns, suggesting potential difficulties in meeting short-term obligations. While the stock price has seen a slight increase of 1.25%, the overall financial health appears precarious, warranting caution for potential investors.
Loading financial metrics...
Company has $412K in cash but burned $530K last quarter. At this burn rate, only 0.8 quarters of runway remain without additional financing.
Company posted a loss of $-3.7M over the last year, representing Infinity% of revenue.
Debt of $4.6M is 11.1x the company's cash position of $412K.
Operating cash flow has been negative for 3 consecutive quarters, burning $2.1M over the last year.
No significant opportunities identified
Based on current financial metrics
Valuation, risk assessment, competitive positioning, and key insights — all in one report.
Other Medical Instruments & Supplies companies of a similar size
Based on 2025-Q2 (June 30, 2025)